Firas El Chaer, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001) (NCT05284032) | Firas El Chaer, MD | 2022-11-29 |
Track Firas El Chaer, MD automatically
Every clearance here is in the API, with alerts when new ones post.